1,25-Dihydroxyvitamin D3 enhances systemic and mucosal immune responses to inactivated poliovirus vaccine in mice

Journal of Infectious Diseases

Volumn 193, Issue 4, 2006, Pages 598-600

  Ivanov, Alexander P ^a,b   Dragunsky, Eugenia M ^a   Chumakov, Konstantin M ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b HFM 470 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; INACTIVATED VACCINE; NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE; POLIOMYELITIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; POLIOMYELITIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SALIVA ANALYSIS; SEROTYPE; VACCINATION;

ANIMALS; DISEASE MODELS, ANIMAL; IMMUNITY; IMMUNITY, MUCOSAL; MICE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; VACCINES, INACTIVATED; VITAMIN D;

EID: 32044434217     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/499970     Document Type: Article

References (12)

1. Murphy BR. Mucosal immunity to viruses. In: Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstok J, McGhee JR. (eds). Mucosal immunology. San Diego, CA: Academic Press, 1999:695-707.
2. Lemire JM. Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem 1992; 49:29-31.
3. Kenney RT, Edelman R. Survey of human-use adjuvants. Expert Rev Vaccines 2003; 2:167-88.
4. Enioutina EY, Visic D, McGee ZA, Daynes RA. The induction of systemic and mucosal immune responses following the subcutaneous immunization of mature adult mice: characterization of the antibodies in mucosal secretions of animals immunized with antigen formulations containing a vitamin D3 adjuvant. Vaccine 1999; 17:3050-64.
5. Daynes RA, Enioutina EY, Butler S, et al. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun 1996; 64:1100-9.
6. Kriesel JD, Spruance J. Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 1999; 17:1883-8.
7. Dragunsky EM, Ivanov AP, Wells VR, et al. Evaluation of immunogenicity and protective properties of inactivated poliovirus vaccines: a new surrogate method for predicting vaccine efficacy. J Infect Dis 2004; 190:1404-12.
8. Ivanov AP, Tkachenko EA, Petrov VA, et al. Enzyme immunoassay for the detection of virus specific IgG and IgM antibody in patients with haemorrhagic fever with renal syndrome. Arch Virol 1988; 100:1-7.
9. Ivanov A, Dragunsky E, Ivanova O, Rezapkin G, Potapova S, Chumakov K. Determination of poliovirus-specific IgA in saliva by ELISA tests. J Virol Methods 2005; 126:45-52.
10. Klasse PJ, Sattentau QJ. Mechanisms of virus neutralization by antibodies. Curr Top Microbiol Immunol 2001; 260:87-108.
11. World Health Organization. WHO global action plan for laboratory containment of wild polioviruses. 2nd ed. Geneva: World Health Organization, 2002.
12. Martin J, Grassland G, Wood DJ, et al. Characterization of formaldehyde-inactivated poliovirus preparations made from live-attenuated strains: risk of reintroduction of polio after eradication: the vaccine origin of an outbreak of type 3 poliomyelitis: the scientific basis for stopping polio immunization-issues and challenges. J Gen Virol 2003; 84:1781-8.